Experimental cancer drug trial halted early
NCT ID NCT06188208
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called VVD-130850, which blocks a protein (STAT3) that helps cancers grow. The trial aimed to find a safe dose and see if the drug works, both alone and with another immunotherapy, in people with advanced solid tumors or blood cancers. The study was terminated before completion, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEMATOLOGIC TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Blacktown Hospital
Blacktown, New South Wales, Australia
-
California Research Institute
Los Angeles, California, 90027, United States
-
Cancer Research South Australia
Adelaide, Australia
-
Florida Cancer Specialists
Sarasota, Florida, 34232, United States
-
Gold Coast University Hospital
Southport, Queensland, Australia
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
ICON Cancer Research
South Brisbane, Australia
-
MDACC
Houston, Texas, 77030, United States
-
NEXT Austin
Austin, Texas, 78758, United States
-
NEXT Dallas
Irving, Texas, 75039, United States
-
NEXT Madrid
Madrid, Spain
-
NEXT San Antonio
San Antonio, Texas, 78299, United States
-
NEXT Virginia
Fairfax, Virginia, 22031, United States
-
Orange Health Service
Orange, New South Wales, Australia
-
START Barcelona Hospital HM Nou Delfos
Barcelona, Spain
-
START Madrid CIOCC
Madrid, Spain
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Start Madrid-FJD, Hospital Fundacion Jimenez Diaz
Madrid, Spain
-
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Vall d'Hebron
Barcelona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.